Minnesota biotech firm Vyriad raises $29.5 million for cancer-fighting viruses

Vyriad Inc., a company that's engineering cancer-killing viruses, announced Tuesday it raised $29.5 million in Series B funding.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 17, 2022 Category: Pharmaceuticals Authors: Carter Jones Source Type: news